I am particularly chagrined at IWIRX's bad one-year performance (barely above water), especially given that most world growth stock funds have done pretty well over the same period. Assets are not great, but the fund grew quickly in relative size in 2014 when it got noticed. A glance at the holdings does not reveal a group of companies that strike me as overly innovative. Healthcare holdings are minuscule compared to the benchmark, probably a brake on performance. Cash is reported as practically nil. Anyone else in this fund?
Comments
http://www.gafunds.com/wp-content/uploads/2013/01/global_innovators_fund_fs.pdf
The annual report should be out shortly, should be interesting.
Now, nothing wrong with this. We have to make decisions in the PRESENT. Hindsight is always 20/20. Hopefully our decision is objective - whether it is correct or wrong only time and no one else can tell - (a) why we bought the fund, (b) has anything changed.
If performance was the sole reason we bought the fund, then IMHO we are doomed to repeat history. And is why index proponents think active investors are smoking crack.
Regards,
Ted
http://money.usnews.com/funds/mutual-funds/world-stock/guinness-atkinson-global-innovators-fund/iwirx